Recent Finacing
Recent Raise
Rodos Biotarget develops TargoSphere, a GMP-scalable nanocarrier platform for targeted delivery of drugs and vaccines to antigen-presenting cells, applied across infections, cancers, autoimmune and liver diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
